drugset / Trial / NCT01327599
Efficacy of Changing to DUOTRAV® From Prior Therapy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to assess the efficacy and tolerability of changing to DUOTRAV® from prior bimatoprost 0.03%/timolol 0.5% pharmacotherapy in subjects with open-angle glaucoma or ocular hypertension having uncontrolled intraocular pressure (IOP).
Timeline
- Start
- 2011-08
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Travoprost 0.004%+Timolol 0.5% ophthalmic solution | Unknown | 0.004 % | Topical |
| Subject | Travoprost 0.004%+Timolol 0.5% ophthalmic solution | Unknown | 0.5 % | Topical |